Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32704517
&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215
Willingness to Seek Diagnostic Testing for SARS-CoV-2 With Home, Drive-through,
and Clinic-Based Specimen Collection Locations
#MMPMID32704517
Siegler AJ
; Hall E
; Luisi N
; Zlotorzynska M
; Wilde G
; Sanchez T
; Bradley H
; Sullivan PS
Open Forum Infect Dis
2020[Jul]; 7
(7
): ofaa269
PMID32704517
show ga
BACKGROUND: SARS-CoV-2 virus testing for persons with COVID-19 symptoms, and
contact tracing for those testing positive, will be critical to successful
epidemic control. Willingness of persons experiencing symptoms to seek testing
may determine the success of this strategy. METHODS: A cross-sectional online
survey in the United States measured willingness to seek testing if feeling ill
under different specimen collection scenarios: home-based saliva, home-based
swab, drive-through facility swab, and clinic-based swab. Instructions clarified
that home-collected specimens would be mailed to a laboratory for testing. We
presented similar willingness questions regarding testing during follow-up care.
RESULTS: Of 1435 participants, comprising a broad range of sociodemographic
groups, 92% were willing to test with a home saliva specimen, 88% with home swab,
71% with drive-through swab, and 60% with clinic-collected swab. Moreover, 68%
indicated they would be more likely to get tested if there was a home testing
option. There were no significant differences in willingness items across
sociodemographic variables or for those currently experiencing COVID-19 symptoms.
Results were nearly identical for willingness to receive testing for follow-up
COVID-19 care. CONCLUSIONS: We observed a hierarchy of willingness to test for
SARS-CoV-2, ordered by the degree of contact required. Home specimen collection
options could result in up to one-third more symptomatic persons seeking testing,
facilitating contact tracing and optimal clinical care. Remote specimen
collection options may ease supply chain challenges and decrease the likelihood
of nosocomial transmission. As home specimen collection options receive
regulatory approval, they should be scaled rapidly by health systems.
free
free
free
